Sleeping Bruxism Market Size & Outlook, 2025-2033

Sleeping Bruxism Market Size

The global sleeping bruxism market size was valued at USD 680.85 million in 2024 and is projected to reach from USD 726.47 million in 2025 to USD 1220.48 million by 2033, growing at a CAGR of 6.7% during the forecast period (2025-2033).

Sleep bruxism is a medical condition that is commonly associated with clenching or grinding of the teeth while a person is asleep. It is an oral habit that includes temporomandibular muscle movement. People who clench or grind their teeth (brux) during sleep are more likely to have dental fractures, tooth loss, inflammation, the excess strain on dental implants, muscle pain, rise in periodontal problems, gingival recession, and sleep disorders, such as sleep apnea and snoring.

According to several researchers, sleeping bruxism has a genetic component that can run in families. Stress is one of the significant risk reasons for the condition. Large-scale population-based epidemiological studies found that the prevalence of the condition varies between 4.4 to 31.4%. Other research studies conducted in specific populations revealed a higher prevalence that is up to 50.2%. Current treatments include stress reduction techniques, medications, various mouth guards and mouthpieces, and other symptom relief methods such as facial exercises, ice packs, or hot compresses.

Factors such as the growing infant population, growing prevalence of obstructive sleep apnea, changing lifestyle, and the growing incidences of sleeping bruxism globally drive the market growth for sleeping bruxism treatment. However, the high cost of custom-fit night guards and lack of standard treatment for this condition is expected to restrain the market growth during the forecast period.

To get more insights about this report Download Free Sample Report

Market Dynamics

Growing Prevalence of Obstructive Sleep Apnea to Propel the Market

Sleep apnea is a sleeping disorder characterized by multiple extended pauses in breathing while sleeping. This abnormal sleeping causes low-quality sleep and affects oxygen supply to the body leading to serious health concerns. Obstructive sleep apnea is a disorder where the airway at the back of the throat gets physically blocked, causing temporary lapses in the breath. 

According to Sleepfoundation.org, obstructive sleep apnea is expected to affect 2-9% of adults in the US. Moreover, according to an article published in The Lancet in 2019, approximately 936 million (95% CI 903–970) adults of age between 30 to 69 years showed the signs of mild to severe obstructive sleep apnea, and nearly 425 million (399–450) adults suffered from moderate to severe obstructive sleep apnea across the world. It is further reported that China, followed by the USA, Brazil, and India, had the highest number of individuals with sleep apnea. This is expected to enhance the market growth during the forecast period. 

Rising Infant Population to Fuel the Market Growth

Sleeping bruxism is found commonly among children. Several research studies have found that around 6% to 50% of children experience teeth grinding during sleep. It can affect children as soon as teeth erupt, hence many infants and toddlers grind their teeth or clench their jaw.

 As per the statistics of the Census of India, in 2019, India has recorded about 164.5 million infant population, which is about 660 thousand, more than the number recorded in 2001. Additionally, according to child trends.org, the global child population was recorded at about 74.1 million in 2020. The growth in the infant population is influencing the prevalence of sleep bruxism and thus, driving the overall market growth.

Regional Analysis

The regional analysis has been made considering the trends of the global market, in North America, Europe, Asia-Pacific, South America, the Middle East, and Africa regions.

The Americas Dominated the Global Market

The American regional market holds a significant market share during the forecast period and is expected to grow at a high CAGR. At the country level, the U.S. is expected to generate huge revenue. The strong regional market can be attributed to the increasing use of psychoactive substances, including anti-depressants, the growing prevalence of chronic sleep disorders, and lifestyle change. Additionally, the prominent market players in the US and Canada are driving America’s market growth.

Asia-Pacific Anticipated to Show Promising Market Growth

The Asia-Pacific market is expected to witness the highest CAGR during the forecast period. The growth can attribute to, rise in the pediatric population, growing awareness about the benefits of early detection of sleeping bruxism, and a rise in stress and anxiety problems among the population.

For instance, according to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the total pediatric population aged between 0 to 14 years is estimated to rise up to 17.7% by 2050. Furthermore, the rise in healthcare investments, growth in population, and a rise in adoption of advanced healthcare technology is expected to propel the market growth during the forecast period.

Segmental Analysis

Dental Approaches to Dominate the Treatment Type Segment

Based on treatment type, the dental approaches segment held the largest market share in 2019 and is anticipated to maintain its supremacy over the projected period, primarily due to its ability to prevent clenching and teeth grinding. The dental approaches segment is further segmented into the mouth guard and NTI-TSS Device. Several randomized controlled trial studies concluded that the NTI-TSS device may be successfully used for the management of sleep bruxism. These night guards and mouthpieces act as a barrier against teeth grinding as they stabilize the mouth and jaw in a specific position to prevent clenching. Dental splints are specially designed by a dentist for a patient’s mouth and can cover whole upper or lower teeth or just a section of teeth.

On the other hand, the medications segment is anticipated to show the highest growth during the forecast period. This is attributed to their function by altering brain chemicals for the reduction of muscle activity that is involved in grinding and clenching. And Botox injections are proved to be effective in severe cases of sleep bruxism.

Hospitals Held Largest Share by End-User Segment

Based on End-user segment, the hospitals segment is accounted for the largest share of the market in 2019. This is due to the growing adoption of newer and innovative treatment solutions, rise in prevalence, and growing awareness.

On the other hand, dental clinics are anticipated to attain the highest growth. The effective management of sleep bruxism with various types of mouthpieces and mouth guards will aid the market growth during the forecast period.

List of key players in Sleeping Bruxism Market

1. Ivoclar Vivadent AG
2. Ipsen Biopharmaceuticals, Inc. 
3. Merz Pharma GmbH and Co. KGaA
4. Carestream Dental
5. Akervall Technologies Inc.
6. PLANMECA OY
7. Randmark Dental Treatment Types, LLC 
8. Patterson Dental Supply, Inc.
9. Henry Schein, Inc.
10. Royal DSM

To get more findings about this report Download Market Share

Recent Developments

• In January 2019, Akervall Technologies Inc. launched SISU Sense, a smart mouthguard in the Las Vegas, and the US, with the aim to extend their product portfolio

• In April 2018, Royal DSM announced a partnership with 3Dmouthguard, to develop custom-made 3D printed mouth guards to protect teeth and mouth injuries